Publisher
Springer Berlin Heidelberg
Reference47 articles.
1. Bartolomei M, Mazzetta C, Handkiewicz-Junak D et al (2004) Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide. Q J Nucl Med Mol Imaging 48:220–228
2. Bigner DD, Brown MT, Friedman AH et al (1998) Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. J Clin Oncol 16:2202–2212
3. Boiardi A, Bartolomei M, Silvani A et al (2005) Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma. J Neurooncol 72:125–131
4. Brack SS, Silacci M, Birchler M et al (2006) Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C. Clin Cancer Res 12:3200–3208
5. Brady LW, Markoe AM, Woo DV et al (1990a) Iodine-125-labeled anti-epidermal growth factor receptor-425 in the treatment of glioblastoma multiforme: a pilot study. Front Radiat Ther Oncol 24:151–160 (discussion 161–165)